Vascular biogenics ltd. (VBLT)
Income statement / Yearly
Dec'17Dec'16Dec'15
REVENUES

13,864

0

0

COST OF REVENUES

-340

0

0

GROSS PROFIT

13,524

0

0

RESEARCH AND DEVELOPMENT EXPENSES, net

-17,770

-12,447

-11,198

MARKETING EXPENSES

-562

0

0

GENERAL AND ADMINISTRATIVE EXPENSES

-5,847

-3,828

-3,673

OPERATING LOSS

10,655

16,275

14,871

FINANCIAL INCOME

-544

-285

-100

FINANCIAL EXPENSES

27

12

117

FINANCIAL EXPENSES (INCOME), net

-517

-273

17

LOSS FOR THE YEAR

10,138

16,002

14,888

OTHER COMPREHENSIVE LOSS (INCOME)-
Items that will not be reclassified to profit or loss-Re-measurements of post-employment benefit obligation

24

5

-6

COMPREHENSIVE LOSS

10,162

16,007

14,882

LOSS PER ORDINARY SHARE
Basic and diluted

0.37

0.64

0.73

WEIGHTED AVERAGE ORDINARY SHARES OUTSTANDING-
Basic and diluted

27,398

24,970

20,309